Cover Image - Diabetes Research and Clinical Practice, Volume 197, Issue
Current Issue
Diabetes Research and Clinical Practice

Articles in Press

Diabetes Atlas

Issue Highlights


Call for data contribution to the 11th edition of IDF's Diabetes Atlas (2024)

Salpea P, Huang Y, Genitsaridi I, Magliano D, Boyko E

International Diabetes Federation, Brussels, Belgium

The International Diabetes Federation (IDF) seeks new data sources of diabetes prevalence to include in the 11th edition of the IDF Diabetes Atlas to be published in 2024.  Click here


Diabetes Research and Clinical Practice

Cover Image - Diabetes Research and Clinical Practice, Volume 197, Issue

Diabetes Research and Clinical Practice

Diabetes Research and Clinical Practice is an international journal for health-care providers and clinically oriented researchers that publishes high-quality original research articles and expert reviews in diabetes and related areas. The role of the journal is to provide a venue for dissemination of knowledge and discussion of topics related to diabetes clinical research and patient care. Topics of focus include translational science, genetics, immunology, nutrition, psychosocial research, epidemiology, prevention, socio-economic research, complications, new treatments, technologies and therapy.

Diabetes Research and Clinical Practice is a transformative journal.

Learn more about APCs and our commitment to OA.

IDF Information

IDF Logo

The International Diabetes Federation (IDF) is an umbrella organization of 221 member associations in more than 160 countries, representing over 285 million people with diabetes, their families, and their healthcare providers. The mission of IDF is to promote diabetes care, prevention and a cure worldwide. Its main activities include education for people with diabetes and healthcare professionals, public awareness campaigns and the promotion and exchange of information. IDF is a non-governmental organization in official relations with WHO and associated to the United Nations’ Department of Public Information. For more information, please visit



COVID-19 and Diabetes: A Call To Action

The COVID-19 pandemic presents humanity with a health crisis as never in the past. And, as in many other instances, people with diabetes are paying a very high price.

Data are, unfortunately, showing that people with diabetes are at higher risk of contracting COVID-19 and that the prognosis is quite poor. Also in the daily management of their disease, because of the restrictions applied by many Governments, they have to face tough challenges in getting needed treatments as well as the required support of specialists and other health-care professionals, all fully engaged in the COVID-19 battle. At the same time, in such a difficult health crisis, they likely are not receiving the most appropriate management when hospitalized.

Diabetes Research and Clinical Practice, with its long affiliation to the International Diabetes Federation, is committed to playing a positive role during this crisis.

We the Editors of DRCP guarantee a fast-track process for any relevant research regarding diabetes and COVID-19 and free access to accepted papers. Our aim is to serve as a quick, trusted and authoritative platform for disseminating new diabetes research relating to the COVID-19 pandemic, with the aim of better serving people with diabetes all around the world.

For all these reasons, with this call, Diabetes Research and Clinical Practice invites scientists from all around the world to submit their research in this field.

Antonio Ceriello, MD
March, 2020


Stephen Colagiuri

Professor Ceriello of Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain and the Department of Cardiovascular and Metabolic Diseases, IRCCS MultiMedica, Milan

Most Read (Last 30 Days)

Most Cited (Previous 3 Years)